Journal
ANTIBIOTICS-BASEL
Volume 10, Issue 3, Pages -Publisher
MDPI
DOI: 10.3390/antibiotics10030306
Keywords
bacteriocins; biofilm; Galleria mellonella; vulvovaginitis
Categories
Ask authors/readers for more resources
The study showed that BLISs from lactobacilli and streptococci have inhibitory effects on Candida species, with good stability against heat, pH, and surfactants but sensitivity to proteases. In vivo testing using Galleria mellonella larvae model demonstrated that BLISs significantly improved survival rates when treated with Candida isolates, suggesting the potential of BLISs as biotherapeutic agents in vulvovaginal candidiasis.
Probiotics can potentially prevent and treat diseases. We examined the inhibitory activity of bacteriocin-like inhibitory substances (BLISs) from potentially probiotic lactobacilli and streptococci on Candida albicans and non-Candida albicans clinical isolates from women with vulvovaginitis. Using agar well diffusion assays, BLISs inhibited both Candida albicans and non-Candida albicans isolates. The BLIS from L. pentosus isolates had the highest anti-Candida activity (33/45; 73.3%), followed by BLISs from isolates of L. paracasei subsp. paracasei (31/45; 68.9%), L. rhamnosus I (30/45; 66.7%), L. delbrueckii subsp. lactis I (30/45; 66.7%), and S. uberis II (30/45; 66.7%). Upon characterization according to the retained activity under variable physical and chemical conditions, the BLISs showed stability against heat, pH, and surfactants, but were protease-sensitive, which suggests a proteinaceous nature of the active substances. Using crystal violet assays, the BLISs reduced the Candida biofilm biomass significantly as compared to a control group that lacked BLISs. In vivo testing of the antagonistic activity was performed using the Galleria mellonella (G. mellonella) larvae model. BLISs significantly improved survival in G. mellonella larvae treated with Candida isolates on the first, second, and seventh days, as compared to larvae inoculated with Candida only (p < 0.01). The results show that BLISs can be used as biotherapeutic agents in vulvovaginal candidiasis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available